Chapter/Section Purchase

1 Study Coverage
1.1 Pancreatic Endocrine Tumor Drug Product Introduction
1.2 Market by Type
1.2.1 Global Pancreatic Endocrine Tumor Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Buparlisib Hydrochloride
1.2.3 Dovitinib Lactate
1.2.4 Fosbretabulin Tromethamine
1.2.5 Lanreotide Acetate
1.2.6 MPHE-001B
1.2.7 Others
1.3 Market by Application
1.3.1 Global Pancreatic Endocrine Tumor Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Research Center
1.3.4 Hospital
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pancreatic Endocrine Tumor Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Pancreatic Endocrine Tumor Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Pancreatic Endocrine Tumor Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pancreatic Endocrine Tumor Drug Sales by Region
2.4.1 Global Pancreatic Endocrine Tumor Drug Sales by Region (2017-2022)
2.4.2 Global Sales Pancreatic Endocrine Tumor Drug by Region (2023-2028)
2.5 Global Pancreatic Endocrine Tumor Drug Revenue by Region
2.5.1 Global Pancreatic Endocrine Tumor Drug Revenue by Region (2017-2022)
2.5.2 Global Pancreatic Endocrine Tumor Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pancreatic Endocrine Tumor Drug Sales by Manufacturers
3.1.1 Global Top Pancreatic Endocrine Tumor Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Pancreatic Endocrine Tumor Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pancreatic Endocrine Tumor Drug in 2021
3.2 Global Pancreatic Endocrine Tumor Drug Revenue by Manufacturers
3.2.1 Global Pancreatic Endocrine Tumor Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Pancreatic Endocrine Tumor Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pancreatic Endocrine Tumor Drug Revenue in 2021
3.3 Global Pancreatic Endocrine Tumor Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pancreatic Endocrine Tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pancreatic Endocrine Tumor Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pancreatic Endocrine Tumor Drug Sales by Type
4.1.1 Global Pancreatic Endocrine Tumor Drug Historical Sales by Type (2017-2022)
4.1.2 Global Pancreatic Endocrine Tumor Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2017-2028)
4.2 Global Pancreatic Endocrine Tumor Drug Revenue by Type
4.2.1 Global Pancreatic Endocrine Tumor Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Pancreatic Endocrine Tumor Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pancreatic Endocrine Tumor Drug Revenue Market Share by Type (2017-2028)
4.3 Global Pancreatic Endocrine Tumor Drug Price by Type
4.3.1 Global Pancreatic Endocrine Tumor Drug Price by Type (2017-2022)
4.3.2 Global Pancreatic Endocrine Tumor Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pancreatic Endocrine Tumor Drug Sales by Application
5.1.1 Global Pancreatic Endocrine Tumor Drug Historical Sales by Application (2017-2022)
5.1.2 Global Pancreatic Endocrine Tumor Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2017-2028)
5.2 Global Pancreatic Endocrine Tumor Drug Revenue by Application
5.2.1 Global Pancreatic Endocrine Tumor Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Pancreatic Endocrine Tumor Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pancreatic Endocrine Tumor Drug Revenue Market Share by Application (2017-2028)
5.3 Global Pancreatic Endocrine Tumor Drug Price by Application
5.3.1 Global Pancreatic Endocrine Tumor Drug Price by Application (2017-2022)
5.3.2 Global Pancreatic Endocrine Tumor Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pancreatic Endocrine Tumor Drug Market Size by Type
6.1.1 North America Pancreatic Endocrine Tumor Drug Sales by Type (2017-2028)
6.1.2 North America Pancreatic Endocrine Tumor Drug Revenue by Type (2017-2028)
6.2 North America Pancreatic Endocrine Tumor Drug Market Size by Application
6.2.1 North America Pancreatic Endocrine Tumor Drug Sales by Application (2017-2028)
6.2.2 North America Pancreatic Endocrine Tumor Drug Revenue by Application (2017-2028)
6.3 North America Pancreatic Endocrine Tumor Drug Market Size by Country
6.3.1 North America Pancreatic Endocrine Tumor Drug Sales by Country (2017-2028)
6.3.2 North America Pancreatic Endocrine Tumor Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Pancreatic Endocrine Tumor Drug Market Size by Type
7.1.1 Europe Pancreatic Endocrine Tumor Drug Sales by Type (2017-2028)
7.1.2 Europe Pancreatic Endocrine Tumor Drug Revenue by Type (2017-2028)
7.2 Europe Pancreatic Endocrine Tumor Drug Market Size by Application
7.2.1 Europe Pancreatic Endocrine Tumor Drug Sales by Application (2017-2028)
7.2.2 Europe Pancreatic Endocrine Tumor Drug Revenue by Application (2017-2028)
7.3 Europe Pancreatic Endocrine Tumor Drug Market Size by Country
7.3.1 Europe Pancreatic Endocrine Tumor Drug Sales by Country (2017-2028)
7.3.2 Europe Pancreatic Endocrine Tumor Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pancreatic Endocrine Tumor Drug Market Size by Type
8.1.1 Asia Pacific Pancreatic Endocrine Tumor Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Pancreatic Endocrine Tumor Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Pancreatic Endocrine Tumor Drug Market Size by Application
8.2.1 Asia Pacific Pancreatic Endocrine Tumor Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Pancreatic Endocrine Tumor Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Pancreatic Endocrine Tumor Drug Market Size by Region
8.3.1 Asia Pacific Pancreatic Endocrine Tumor Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Pancreatic Endocrine Tumor Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Pancreatic Endocrine Tumor Drug Market Size by Type
9.1.1 Latin America Pancreatic Endocrine Tumor Drug Sales by Type (2017-2028)
9.1.2 Latin America Pancreatic Endocrine Tumor Drug Revenue by Type (2017-2028)
9.2 Latin America Pancreatic Endocrine Tumor Drug Market Size by Application
9.2.1 Latin America Pancreatic Endocrine Tumor Drug Sales by Application (2017-2028)
9.2.2 Latin America Pancreatic Endocrine Tumor Drug Revenue by Application (2017-2028)
9.3 Latin America Pancreatic Endocrine Tumor Drug Market Size by Country
9.3.1 Latin America Pancreatic Endocrine Tumor Drug Sales by Country (2017-2028)
9.3.2 Latin America Pancreatic Endocrine Tumor Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pancreatic Endocrine Tumor Drug Market Size by Type
10.1.1 Middle East and Africa Pancreatic Endocrine Tumor Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pancreatic Endocrine Tumor Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Pancreatic Endocrine Tumor Drug Market Size by Application
10.2.1 Middle East and Africa Pancreatic Endocrine Tumor Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pancreatic Endocrine Tumor Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Pancreatic Endocrine Tumor Drug Market Size by Country
10.3.1 Middle East and Africa Pancreatic Endocrine Tumor Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pancreatic Endocrine Tumor Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Ipsen S.A.
11.1.1 Ipsen S.A. Corporation Information
11.1.2 Ipsen S.A. Overview
11.1.3 Ipsen S.A. Pancreatic Endocrine Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Ipsen S.A. Pancreatic Endocrine Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Ipsen S.A. Recent Developments
11.2 Jiangsu Hengrui Medicine Co., Ltd.
11.2.1 Jiangsu Hengrui Medicine Co., Ltd. Corporation Information
11.2.2 Jiangsu Hengrui Medicine Co., Ltd. Overview
11.2.3 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
11.3 MediaPharma s.r.l.
11.3.1 MediaPharma s.r.l. Corporation Information
11.3.2 MediaPharma s.r.l. Overview
11.3.3 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 MediaPharma s.r.l. Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Corporation Information
11.4.2 Novartis AG Overview
11.4.3 Novartis AG Pancreatic Endocrine Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novartis AG Pancreatic Endocrine Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis AG Recent Developments
11.5 OXiGENE, Inc.
11.5.1 OXiGENE, Inc. Corporation Information
11.5.2 OXiGENE, Inc. Overview
11.5.3 OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 OXiGENE, Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pancreatic Endocrine Tumor Drug Industry Chain Analysis
12.2 Pancreatic Endocrine Tumor Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pancreatic Endocrine Tumor Drug Production Mode & Process
12.4 Pancreatic Endocrine Tumor Drug Sales and Marketing
12.4.1 Pancreatic Endocrine Tumor Drug Sales Channels
12.4.2 Pancreatic Endocrine Tumor Drug Distributors
12.5 Pancreatic Endocrine Tumor Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pancreatic Endocrine Tumor Drug Industry Trends
13.2 Pancreatic Endocrine Tumor Drug Market Drivers
13.3 Pancreatic Endocrine Tumor Drug Market Challenges
13.4 Pancreatic Endocrine Tumor Drug Market Restraints
14 Key Findings in The Global Pancreatic Endocrine Tumor Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer